New questions about the future of the hemp industry emerged after one of the largest CBD processors filed for bankruptcy, but advocates remain bullish about the long-term future — if they can get more answers out of FDA.
Two consumers have filed a class-action lawsuit against a California CBD company for selling unapproved drugs, dietary supplements and foods, the latest in a series of suits that have hit the CBD industry since the Food and Drug Administration sent warning letters to 15 companies last month.
CBD products are marketed almost everywhere these days, and hemp farmers are counting on this new, emerging market to bolster their revenues. However, the U.S. Food and Drug Administration (FDA) is stepping up its warnings on CBD in dietary supplements and food products
When it comes to food or “health” products containing cannabidiol, commonly known as CBD, the federal government is not keeping up with the marketplace, where sales of CBD products topped $500 million in 2018.